All Stories

  1. Pharmacological Strategies to Improve Dendritic Spines in Alzheimer’s Disease
  2. A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease
  3. New Targets and Strategies of Medical Treatments in Neurological and Neurodegenerative Disorders
  4. Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
  5. The Ethyl Acetate Extract of Leaves of Ugni molinae Turcz. Improves Neuropathological Hallmarks of Alzheimer’s Disease in Female APPswe/PS1dE9 Mice Fed with a High Fat Diet
  6. Experimental Models for Aging and their Potential for Novel Drug Discovery
  7. 3,4-Methylenedioxymethamphetamine enhances kainic acid convulsive susceptibility
  8. MDMA enhances hippocampal-dependent learning and memory under restrictive conditions, and modifies hippocampal spine density
  9. Metabolic Basis of Sporadic Alzeimer’s Disease. Role of Hormones Related to Energy Metabolism
  10. Editorial: Advances in the Treatment of Neurodegenerative Diseases and Epilepsy
  11. Depression-like behavior is dependent on age in male SAMP8 mice
  12. Cyclin-Dependent Kinases
  13. Intracellular Pathways Associated with Neuronal Survival and Death in Epilepsy
  14. Modifications in the Seizures Susceptibility by Excitotoxic Neuronal Damage and Its Possible Relationship with the Pharmacoresistance
  15. Physiological and behavioural consequences of long-term moderate treadmill exercise
  16. Neuroprotective and anti-ageing role of leptin
  17. Antiapoptotic effects of roscovitine on camptothecin-induced DNA damage in neuroblastoma cells
  18. Content and traffic of taurine in hippocampal reactive astrocytes
  19. Cerebral Amyloid Angiopathy, Blood-Brain Barrier Disruption and Amyloid Accumulation in SAMP8 Mice
  20. Aging control with resveratrol
  21. Resveratrol: A Therapeutic Approach to Neurodegenerative Diseases and Aging
  22. Role of Calpain in Apoptotic Process Involved in Neurodegenerative Diseases
  23. Kainate-induced toxicity in the hippocampus: potential role of lithium
  24. Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases
  25. Synthesis, uptake and release of taurine in astrocytes treated with 8-Br-cAMP
  26. Potential Mechanisms Involved in the Prevention of Neurodegenerative Diseases by Lithium
  27. Sirtuin and Resveratrol
  28. Anti-aging properties of melatonin in an in vitro murine senescence model: involvement of the sirtuin 1 pathway
  29. Calpains as a Target for Therapy of Neurodegenerative Diseases: Putative Role of Lithium
  30. Age-related expression of adenosine receptors in brain from the senescence-accelerated mouse
  31. Role of cdk5 on ATM phosphorylation in neuronal death induced by DNA damage
  32. Prevention of epilepsy by taurine treatments in mice experimental model
  33. Resveratrol and Neurodegenerative Diseases: Activation of SIRT1 as the Potential Pathway towards Neuroprotection
  34. The p38MAPK signaling pathway regulates neuronal apoptosis through the phosphorylation of the retinoblastoma protein
  35. Evidence of calpain/cdk5 pathway inhibition by lithium in 3-nitropropionic acid toxicity in vivo and in vitro
  36. Melatonin alters cell death processes in response to age-related oxidative stress in the brain of senescence-accelerated mice
  37. Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid
  38. Regulation of GSK-3β by calpain in the 3-nitropropionic acid model
  39. Evaluation of potential pro-survival pathways regulated by melatonin in a murine senescence model
  40. Favorable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescence-accelerated mice
  41. Modulation of Sirtuins: New Targets for Antiageing
  42. Apoptotic mechanisms involved in neurodegenerative diseases: Experimental and therapeutic approaches
  43. Implication of the transcription factor E2F-1 in the modulation of neuronal apoptosis
  44. 3-Nitropropionic acid activates calpain/cdk5 pathway in rat striatum
  45. Kainate induces AKT, ERK and cdk5/GSK3β pathway deregulation, phosphorylates tau protein in mouse hippocampus
  46. Molecular and Biochemical Features in Alzheimers Disease
  47. Involvement of Calpain Activation in Neurodegenerative Processes
  48. The role of CDK5/P25 formation/inhibition in neurodegeneration
  49. Evaluation of the neuronal apoptotic pathways involved in cytoskeletal disruption-induced apoptosis
  50. Inhibition of the cdk5/MEF2 pathway is involved in the antiapoptotic properties of calpain inhibitors in cerebellar neurons
  51. Free radical production induced by methamphetamine in rat striatal synaptosomes
  52. Flavopiridol: an antitumor drug with potential application in the treatment of neurodegenerative diseases
  53. Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium
  54. Lithium prevents colchicine-induced apoptosis in rat cerebellar granule neurons
  55. Cyclosporin A enhances colchicine-induced apoptosis in rat cerebellar granule neurons
  56. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity
  57. Evaluation of neuronal cell death by laser scanning cytometry
  58. [6] Flow cytometric determination of cytoplasmic oxidants and mitochondrial membrane potential in neuronal cells
  59. Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo
  60. Further characterization of an adenosine transport system in the mitochondrial fraction of rat testis
  61. Evaluation of free radical production, mitochondrial membrane potential and cytoplasmic calcium in mammalian neurons by flow cytometry
  62. Protective effects of C-phycocyanin against kainic acid-induced neuronal damage in rat hippocampus
  63. Cell-surface Expression of Heat Shock proteins in Dog Neutrophils after Oxidative Stress
  64. In vitro and in vivo protective effect of orphenadrine on glutamate neurotoxicity
  65. Effects of U-83836E on Glutamate-Induced Neurotoxicity in Dissociated Rat Cerebellar Granule Cells
  66. Assessment of the Adrenergic Effects of Orphenadrine in Rat Vas Deferens
  67. Activation of nuclear factor-κB in the rat brain after transient focal ischemia
  68. Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats
  69. Flow cytometric study of mitochondrial dysfunction after AMPA receptor activation
  70. U-83836E prevents kainic acid-induced neuronal damage
  71. Reactive Oxygen Production by Glutamate Agonists in Dissociated Cerebellar Cells: A Flow Cytometric Study
  72. Characterization of [3H]nisoxetine binding in rat vas deferens membranes: Modulation by sigma and PCP ligands
  73. Determination of nitric oxide generation in mammalian neurons using dichlorofluorescin diacetate and flow cytometry
  74. Synthesis and Calcium Channel Blocking Activity of 4-Indolyl-1,4-dihydropyridines
  75. Mitochondrial membrane potential measurement in rat cerebellar neurons by flow cytometry
  76. Effect of glutamate receptor ligands on mitochondrial membrane potential in rat dissociated cerebellar cells
  77. Modulation of NMDA-induced cytosolic calcium levels by ACPC in cultured cerebellar granule cells
  78. A flow cytometric study ofN-methyl-d-aspartate effects on dissociated cerebellar cells
  79. Characterization of nitrobenzylthioinosine binding sites in the mitochondrial fraction of rat testis
  80. Cell surface expression of heat shock proteins in dog neutrophils induced by mitochondrial benzodiazepine receptor ligands
  81. A new aspect of the antiproliferative action of peripheral-type benzodiazepine receptor ligands
  82. Flow cytometric studies of NMDA-induced calcium increases and oxidative stress on dissociated cerebellar cells
  83. Characterization and differentiation of peripheral-type benzodiazepine receptors in rat and human prostate
  84. Specific binding sites for [3H]Ro 5-4864 in rat prostate and seminal vesicle
  85. Characterization of [3H]Ro 5-4864 Binding Sites in Rat Vas Deferens